Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)

Basit Öğe Kaydı
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authorwosidCoşkun, Hasan Şenol/C-2070-2016
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.contributor.authorKanesvaran, R.
dc.contributor.authorBiswas, B.
dc.contributor.authorDanchaivijitr, P.
dc.contributor.authorLim, C. S.
dc.contributor.authorKarabulut, B.
dc.contributor.authorWong, Y. F.
dc.contributor.authorCoskun, H. S.
dc.date.accessioned2024-06-12T11:23:59Z
dc.date.available2024-06-12T11:23:59Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.descriptionEuropean-Society-for-Medical-Oncology (ESMO) Asia Congress -- NOV 22-24, 2019 -- Singapore, SINGAPOREen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncolen_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26757
dc.identifier.volume30en_US
dc.identifier.wosWOS:000503487700531en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleReal-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu